First Trust Advisors’s Intellia Therapeutics NTLA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-276,855	Closed	-$2.49M	–	2691
2025 Q4	$2.49M	Buy	276,855 +266,179	+2,493%	+$3.66M	﹤0.01%	1779
2025 Q3	$184K	Buy	10,676 +448	+4%	+$5.52K	﹤0.01%	2514
2025 Q2	$95.9K	Buy	+10,228	New	+$84K	﹤0.01%	2571
2024 Q2	–	Sell	-51,438	Closed	-$1.42M	–	2395
2024 Q1	$1.42M	Buy	+51,438	New	+$1.43M	﹤0.01%	1870
2023 Q4	–	Sell	-33,208	Closed	-$1.05M	–	2403
2023 Q3	$1.05M	Buy	+33,208	New	+$1.29M	﹤0.01%	1947
2022 Q1	–	Sell	-71,282	Closed	-$8.43M	–	2572
2021 Q4	$8.43M	Buy	71,282 +5,826	+9%	+$730K	0.01%	1124
2021 Q3	$8.78M	Sell	65,456 -4,895	-7%	-$741K	0.01%	1044
2021 Q2	$11.4M	Sell	70,351 -24,946	-26%	-$1.94M	0.01%	962
2021 Q1	$7.65M	Buy	95,297 +25,283	+36%	+$1.7M	0.01%	1035
2020 Q4	$3.81M	Buy	+70,014	New	+$2.54M	0.01%	1233
2019 Q1	–	Sell	-67,322	Closed	-$919K	–	2441
2018 Q4	$919K	Sell	67,322 -92,981	-58%	-$1.73M	﹤0.01%	1864
2018 Q3	$4.59M	Buy	160,303 +55,798	+53%	+$1.62M	0.01%	1193
2018 Q2	$2.86M	Buy	+104,505	New	+$2.53M	0.01%	1412